Demo Sign up Log In

Inhibikase Therapeutics Inc (IKT)

Cash Conversion Ratio

0.82×

Quarterly · Period ending: Dec 31, 2023

IKT Cash Conversion Ratio

Latest reported0.82×period endingDec 31, 2023

Latest reported0.82×period endingDec 31, 2023

IKT Quarterly Cash Conversion Ratio (-0.51× → 0.82×)

Latest values, visible window

High-resolution chart · PNG

IKT cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Dec 31, 2023	0.824×
Sep 30, 2023	0.8933×
Jun 30, 2023	0.7926×
Mar 31, 2023	1.3337×
Dec 31, 2022	0.8311×
Sep 30, 2022	1.2693×
Jun 30, 2022	0.948×
Mar 31, 2022	0.8478×
Dec 31, 2021	0.8124×
Sep 30, 2021	0.4519×
Jun 30, 2021	1.6109×
Mar 31, 2021	1.4919×
Dec 31, 2020	0.7836×
Sep 30, 2020	-0.1126×
Jun 30, 2020	0.0253×
Mar 31, 2020	0.4666×
Dec 31, 2019	-0.0148×
Sep 30, 2019	0.0056×
Jun 30, 2019	0.021×
Mar 31, 2019	0.1663×
Dec 31, 2018	-0×
Mar 31, 2018	-0.5117×
Dec 31, 2017	0×
Mar 31, 2017	-0.5069×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.